On May 27, your Academy co-signed a letter sponsored by the North American Neuromodulation Society commenting on Official Disability Guidelines (ODG) proposed policy that would prevent coverage for intrathecal drug delivery systems (IDDS) for all workers’ compensation injuries, including new and current low dose therapies. The letter is in opposition to the ODG proposed policy in effort to preserve patient access to this care.
Read the full letter.
Learn more about AAPM&R's other advocacy efforts.